Keymed Biosciences Inc. (2162.HK)

HKD 33.0

(-1.93%)

Inventory Summary of Keymed Biosciences Inc.

  • Keymed Biosciences Inc.'s latest annual inventory in 2023 was 56.35 Million CNY , up 26.65% from previous year.
  • Keymed Biosciences Inc.'s latest quarterly inventory in 2024 Q1 was 95.95 Million CNY , up 70.27% from previous quarter.
  • Keymed Biosciences Inc. reported annual inventory of 44.49 Million CNY in 2022, up 171.43% from previous year.
  • Keymed Biosciences Inc. reported annual inventory of 16.39 Million CNY in 2021, up 139.45% from previous year.
  • Keymed Biosciences Inc. reported quarterly inventory of 95.95 Million CNY for 2024 Q1, up 70.27% from previous quarter.
  • Keymed Biosciences Inc. reported quarterly inventory of 61.1 Million CNY for 2023 Q3, down -24.03% from previous quarter.

Annual Inventory Chart of Keymed Biosciences Inc. (2023 - 2019)

Historical Annual Inventory of Keymed Biosciences Inc. (2023 - 2019)

Year Inventory Inventory Growth
2023 56.35 Million CNY 26.65%
2022 44.49 Million CNY 171.43%
2021 16.39 Million CNY 139.45%
2020 6.84 Million CNY 107.08%
2019 3.3 Million CNY 0.0%

Peer Inventory Comparison of Keymed Biosciences Inc.

Name Inventory Inventory Difference
Uni-Bio Science Group Limited 36.39 Million HKD -54.853%
CK Life Sciences Int'l., (Holdings) Inc. 1.2 Billion HKD 95.322%